This report describes the external quality assessment (EQA) scheme for the European Legionnaires’ disease Surveillance network, for the detection, isolation, identification, and enumeration of Legionella species.
This report describes the external quality assessment (EQA) scheme for the European Legionnaires’ disease Surveillance network, for the detection, isolation, identification, and enumeration of Legionella spp.
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
This report presents the results of the European External Influenza Quality Assessment Programme 2020 for influenza reference laboratories in the WHO European Region, designed and prepared by the contractor and funded by ECDC and WHO Regional Office for Europe.
This is the first EQA exercise for laboratories participating in surveillance from the ELDSNet network that has been
organised by ECDC since 2015 and the EQA format and arrangements have changed. The current EQA scheme
uses an outbreak scenario with a package of clinical and environmental samples for the participating laboratories to process, depending on their technical capacity and protocols.
This report provides an analysis of the EQA performance of laboratories in the 28 EU/EEA countries in relation to the detection/isolation, identification, enumeration and quantification of Legionella spp. and the further characterisation of L. pneumophila, by serogrouping and sequence-based typing, from both clinical and environmental samples, where applicable.
This is the eighth report for the 2019–20 influenza season. As of week 25/2020, 164 883 influenza detections across the WHO European Region had been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 479 (98%) of 4 568 ascribed to a lineage being B/Victoria.
This is the seventh report for the 2019 2019–20 influenza season. As of week 20 / 16 4 868 influenza detections across the WHO European Region ha have been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 4 479 (98%) of 4 5 568 ascribed to a lineage being B/Victoria.